Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/25 16:39 | 9/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Wei Lin | CA | O | Chief Me | 1 | S | -99 | 45.83 | 0 | -2 | 88 | D | |||||||||||||||
9/18/25 16:38 | 9/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Kelsey Stephen Michael | CA | O | See Rema | 3 | S.dm | -6,395 | 25.04 | 0 | -255 | 289 | D | |||||||||||||||
9/18/25 16:37 | 9/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Goldsmith Mark A | CA | DO | See Rema | 2 | S.d | -635 | 12.59 | 0 | -50 | 972 | D | |||||||||||||||
9/18/25 16:36 | 9/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Horn Margaret A | CA | O | COO | 1 | S | -219 | 45.82 | 0 | -5 | 146 | D | |||||||||||||||
9/18/25 16:35 | 9/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Cislini Jeff | CA | O | GC | 2 | S | -161 | 42.68 | 0 | -4 | 54 | D | |||||||||||||||
9/18/25 16:34 | 9/16/25 | RVMD | Health | BioPrd | Biological Products, (No Diag | Anders Jack | CA | O | CFO | 3 | S.dm | -574 | 25.72 | 0 | -22 | 113 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |